|
US6025154A
(en)
|
1995-06-06 |
2000-02-15 |
Human Genome Sciences, Inc. |
Polynucleotides encoding human G-protein chemokine receptor HDGNR10
|
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
|
CZ106299A3
(cs)
|
1996-09-26 |
1999-08-11 |
Chugai Seiyaku Kabushiki Kaisha |
Protilátky proti proteinu příbuznému s lidským parathyroidálním hormonem
|
|
SE9801098D0
(sv)
*
|
1998-03-30 |
1998-03-30 |
Astra Pharma Prod |
Receptors
|
|
AU3962099A
(en)
*
|
1998-05-07 |
1999-11-23 |
William Douglas Mckee |
Valve assembly
|
|
US6171590B1
(en)
|
1998-09-30 |
2001-01-09 |
Corixa Corporation |
Chemokine receptor peptide for inducing an immune response
|
|
AU1712200A
(en)
*
|
1998-11-06 |
2000-05-29 |
Millennium Pharmaceuticals, Inc. |
G-protein coupled receptors, homologous to ebv-induced gpcr 2 (ebi-2). methods to seek for ligands thereof
|
|
US6329159B1
(en)
*
|
1999-03-11 |
2001-12-11 |
Millennium Pharmaceuticals, Inc. |
Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
|
|
US6358697B2
(en)
*
|
1999-04-21 |
2002-03-19 |
Children's Hospital Medical Center |
Intracellular pharmaceutical targeting
|
|
JP2003506042A
(ja)
|
1999-08-03 |
2003-02-18 |
ミレニアム ファーマシューティカルズ インク． |
セクレチン様ファミリーの新規ｇｐｃｒ様分子１５５７１及びその使用
|
|
CA2389979C
(en)
*
|
1999-11-24 |
2011-08-16 |
Schering Corporation |
Methods of inhibiting metastasis
|
|
US6949243B1
(en)
|
1999-11-24 |
2005-09-27 |
Schering Corporation |
Methods of inhibiting metastasis
|
|
AU2001249546A1
(en)
*
|
2000-03-27 |
2001-10-08 |
Corixa Corporation |
Methods for treating disease with antibodies to cxcr3
|
|
WO2001082968A1
(fr)
|
2000-04-28 |
2001-11-08 |
Chugai Seiyaku Kabushiki Kaisha |
Inhibiteurs de proliferation cellulaire
|
|
US7052676B2
(en)
|
2000-09-26 |
2006-05-30 |
The Regents Of The University Of Michigan |
Methods for inhibition of HIV replication using a small molecule inhibitor
|
|
US7175988B2
(en)
|
2001-02-09 |
2007-02-13 |
Human Genome Sciences, Inc. |
Human G-protein Chemokine Receptor (CCR5) HDGNR10
|
|
JP2005501036A
(ja)
*
|
2001-07-12 |
2005-01-13 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
二次的な組織変性のｃｘｃｌ１０処置
|
|
US7442512B2
(en)
|
2001-11-30 |
2008-10-28 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7253007B2
(en)
|
2001-11-30 |
2007-08-07 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7413866B2
(en)
|
2001-11-30 |
2008-08-19 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7871619B2
(en)
|
2001-11-30 |
2011-01-18 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7393934B2
(en)
|
2001-12-21 |
2008-07-01 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor (CCR5) HDGNR10
|
|
EP1491209A4
(en)
*
|
2002-02-28 |
2006-05-17 |
Kyowa Hakko Kogyo Kk |
MEANS FOR DIAGNOSIS AND TREATMENT OF INTERSTITIAL PNEUMONIA
|
|
WO2003082335A1
(fr)
*
|
2002-04-03 |
2003-10-09 |
Sumitomo Pharmaceuticals Co., Ltd. |
Nouveau dispositif de controle du sucre dans le sang et procede de criblage associe
|
|
AU2003248549B2
(en)
|
2002-05-24 |
2010-04-08 |
Millennium Pharmaceuticals, Inc. |
CCR9 inhibitors and methods of use thereof
|
|
US7741519B2
(en)
|
2007-04-23 |
2010-06-22 |
Chemocentryx, Inc. |
Bis-aryl sulfonamides
|
|
AU2003298661B2
(en)
|
2002-11-18 |
2007-05-10 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
|
US7227035B2
(en)
|
2002-11-18 |
2007-06-05 |
Chemocentryx |
Bis-aryl sulfonamides
|
|
US7420055B2
(en)
|
2002-11-18 |
2008-09-02 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
|
ATE427933T1
(de)
|
2002-12-20 |
2009-04-15 |
Chemocentryx Inc |
Inhibitoren der bindungder chemokine i-tac bzw. sdf-1 an den ccxckr2-rezeptor
|
|
US7834155B2
(en)
|
2003-07-21 |
2010-11-16 |
Immunogen Inc. |
CA6 antigen-specific cytotoxic conjugate and methods of using the same
|
|
EP1631315B1
(en)
*
|
2003-09-24 |
2014-07-30 |
Millennium Pharmaceuticals, Inc. |
Antibodies which bind human cxcr3
|
|
JP4452839B2
(ja)
*
|
2004-03-09 |
2010-04-21 |
国立大学法人京都大学 |
Ｃｘｃｒ３阻害剤を含有する医薬組成物
|
|
WO2005105841A2
(en)
|
2004-03-12 |
2005-11-10 |
Human Genome Sciences, Inc. |
Human g-protein chemokine receptor (ccr5) hdgnr10
|
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
|
DK1871804T3
(da)
|
2005-04-21 |
2013-12-02 |
Chemocentryx Inc |
Antistoffer, der binder CCX-CKR2
|
|
JP2010521413A
(ja)
|
2006-03-16 |
2010-06-24 |
プロタゴニスツ リミテッド |
免疫系機能を改変するためのサイトカインとサイトカイン受容体の組合せ
|
|
US8519135B2
(en)
|
2006-07-14 |
2013-08-27 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2/CCR9
|
|
CA2677163A1
(en)
*
|
2007-02-01 |
2008-08-07 |
Teva Biopharmaceuticals Usa, Inc. |
Humanized antibodies against cxcr3
|
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
|
CA2692761C
(en)
|
2007-07-12 |
2013-04-30 |
Chemocentryx, Inc. |
Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation
|
|
BR112014017814A8
(pt)
*
|
2012-01-20 |
2017-07-11 |
Genzyme Corp |
Anticorpos anti-cxcr3
|
|
WO2014003742A1
(en)
*
|
2012-06-27 |
2014-01-03 |
Morehouse School Of Medicine |
Anti-cxcl9, anti-cxcl10, anti-cxcl11, anti-cxcl13, anti-cxcr3 and anti-cxcr5 agents for inhibition of inflammation
|
|
WO2014008385A1
(en)
|
2012-07-05 |
2014-01-09 |
Cornell University |
Compositions and methods useful for making orthotopic tumors with controllable metastasis
|
|
WO2014186842A1
(en)
*
|
2013-05-22 |
2014-11-27 |
Monash University |
Antibodies and uses thereof
|
|
IL294410B2
(en)
|
2016-11-23 |
2024-02-01 |
Chemocentryx Inc |
A method for the treatment of focal segmental tuberous sclerosis
|
|
CA3045944A1
(en)
|
2016-12-07 |
2018-06-14 |
Progenity, Inc. |
Gastrointestinal tract detection methods, devices and systems
|
|
CA3045310A1
(en)
|
2016-12-14 |
2018-06-21 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
|
|
MX386699B
(es)
|
2017-10-11 |
2025-03-19 |
Chemocentryx Inc |
Tratamiento de glomerulosclerosis segmentaria focal con antagonistas ccr2
|
|
CN113348011B
(zh)
|
2018-11-19 |
2023-04-18 |
比奥拉治疗股份有限公司 |
用生物治疗剂治疗疾病的方法和装置
|
|
CN121197633A
(zh)
|
2019-12-13 |
2025-12-26 |
比特比德科有限责任公司 |
用于将治疗剂递送至胃肠道的可摄取装置
|
|
US20240066061A1
(en)
*
|
2021-01-12 |
2024-02-29 |
Charité-Universitätsmedizin Berlin |
A cxcr3+ cell or cell preparation for use in cancer treatment
|
|
WO2025185738A1
(zh)
*
|
2024-03-08 |
2025-09-12 |
演生潮(北京)生物科技有限公司 |
靶向cxcr3的抗原结合蛋白及其应用
|